Non-Invasive Prenatal Testing: UK Genetic Counselors’ Experiences and Perspectives

Journal of Genetic Counseling

Volumn 24, Issue 2, 2015, Pages 300-311

  Alexander, Elizabeth ^a   Kelly, Susan ^b   Kerzin Storrar, Lauren ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Fetal sexing; Gatekeeping; Genetic Counselors; Informed consent; New technologies; NIPT; Non invasive prenatal diagnosis; Service provision; Test accuracy

Indexed keywords

ANEUPLOIDY; BIOLOGICAL MODEL; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MALE; PREGNANCY; PRENATAL DIAGNOSIS; PSYCHOLOGY; RISK FACTOR;

ANEUPLOIDY; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HUMANS; MALE; MODELS, GENETIC; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 84925268846     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-014-9765-9     Document Type: Article

References (63)

1. Barrett, A. N., McDonnell, T. C., Chan, K. C., & Chitty, L. S. (2012). Digital PCR Analysis of Maternal Plasma for Noninvasive Detection of Sickle Cell Anemia. Clinical Chemistry, 58(6), 1026–1032. doi:10.1373/clinchem.2011.178939.
2. Benn, P. A., & Chapman, A. R. (2010). Ethical challenges in providing noninvasive prenatal diagnosis. Current Opinion in Obstetrics and Gynecology, 22, 128–134. doi:10.1097/GCO.0b013e3283372352.
3. Benn, P., Cuckle, H., & Pergament, E. (2012). Non-invasive prenatal diagnosis for Down syndrome: the paradigm will shift, but slowly. Ultrasound in Obstetrics and Gynecology, 39(2), 127–30. doi:10.1002/uog.11083.
4. Bensend, T. A., McCarthy Veach, P., & Niendorf, K. B. (2014). What’s the Harm? Genetic Counselor Perceptions of Adverse Effects of Genetics Service Provision by Non-Genetics Professionals. Journal of Genetic Counseling, 23(1), 48–63. doi:10.1007/s10897-013-9605-3.
5. Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., et al. (2014). DNA sequencing versus standard prenatal aneuploidy screening. New England Journal of Medicine, 370(9), 799–808. doi:10.1056/NEJMoa1311037.
6. Bot-Robin, V., Sendon, S., Bourzoufi, K., Vaast, P., Deken, V., Dutoit, P., & Houfflin-Debarge, V. (2012). Maternal anxiety and pain during prenatal diagnostic techniques: a prospective study. Prenatal Diagnosis, 32(6), 562–568. doi:10.1002/pd.3857.
7. British Society for Genetic Medicine (2014). List of UK Genetic Centres. Retrieved June 10, 2014 from http://www.bsgm.org.uk/information-education/genetics-centres/.
8. Callard, A., Newman, B., & Payne, K. (2012). Delivering a Pharmacogenetic Service: Is There a Role for Genetic Counselors? Journal of Genetic Counseling, 21(4), 527–535. doi:10.1007/s10897-011-9415-4.
9. Chetty, S., Garabedian, M. J., & Norton, M. E. (2013). Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenatal Diagnosis, 33(6), 542–546. doi:10.1002/pd.4125.
10. Chitty, L. S., & Bianchi, D. W. (2013). Noninvasive prenatal testing: the paradigm is shifting rapidly. Prenatal Diagnosis, 33(6), 511–513. doi:10.1002/pd.4136.
11. Chitty, L. S., Hill, M., White, H., Wright, D., & Morris, S. (2012). Noninvasive prenatal testing for aneuploidy–ready for prime time? American Journal of Obstetrics and Gynecology, 206(4), 269–275. doi:10.1016/j.ajog.2012.02.021.
12. Chitty, L. S., Khalil, A., Barrett, A. N., Pajkrt, E., Griffin, D. R., & Cole, T. J. (2013). Safe, accurate, prenatal diagnosis of thanatophoric dysplasia using ultrasound and free fetal DNA. Prenatal Diagnosis, 33(5), 416–423. doi:10.1002/pd.4066.
13. de Jong, A., Dondorp, W. J., de Die-Smulders, C. E., Frints, S. G., & de Wert, G. M. (2010). Non-invasive prenatal testing: ethical issues explored. European Journal of Human Genetics, 18(3), 272–277. doi:10.1038/ejhg.2009.203.
14. Deans, Z., & Newson, A. (2011). Should Non-Invasiveness Change Informed Consent Procedures for Prenatal Diagnosis? Health Care Analysis, 19(2), 122–132. doi:10.1007/s10728-010-0146-8.
15. Devaney, S. A., Palomaki, G. E., Scott, J. A., & Bianchi, D. W. (2011). Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis. The Journal of the American Medical Association, 306(6), 627–636. doi:10.1001/jama.2011.1114.
16. Devers, P. L., Cronister, A., Ormond, K. E., Facio, F., Brasington, C. K., & Flodman, F. (2013). Noninvasive Prenatal Testing/Noninvasive Prenatal Diagnosis: the Position of the National Society of Genetic Counselors. Journal of Genetic Counseling, 22(3), 291–295. doi:10.1007/s10897-012-9564-0.
17. Reliable Accurate Prenatal non-Invasive Diagnosis Study (2013). NIPT for Down syndrome evaluation study Retrieved February 2, 2014, from http://www.rapid.nhs.uk/about-rapid/evaluation-study-nipt-for-down-syndrome/.
18. Edwards, J. G. (2013). The transnational alliance for genetic counseling: promoting international communication and collaboration. Journal for Genetic Counseling, 22(6), 688–689. doi:10.1007/s10897-013-9621-3.
19. Fan, H. C., Gu, W., Wang, J., Blumenfeld, Y. J., El-Sayed, Y. Y., & Quake, S. R. (2012). Non- invasive prenatal measurement of the fetal genome. Nature, 487(7407), 320–324. doi:10.1038/nature11251.
20. Farrelly, E., Cho, M. K., Erby, L., Roter, D., Stenzel, A., & Ormond, K. E. (2012). Genetic counselors and prenatal testing: where is the discussion about disability? Journal of Genetic Counseling, 21(6), 814–824. doi:10.1007/s10897-012-9534-6.
21. Genetic Counsellor Registration Board (GCRB) (2013). Check the Register. Retrieved February 2, 2014, from http://www.gcrb.org.uk/check.html.
22. Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565–574. doi:10.1038/gim.2013.73.
23. Grove, M.E., Wolpert, M.N., Cho, M.K., Soo-Jin Lee, S. and Ormond K.E (2013). Views of Genetics Health Professionals on the Return of Genomic Results. Journal of Genetic Counseling, 22(3). Advance online publication. doi: 10.1007/s10897-013-9611-5
24. Hall, A., Bostanci, A., & Wright, C. F. (2010). Non-Invasive Prenatal Diagnosis Using Cell-Free Fetal DNA Technology: Applications and Implications. Public Health Genomics, 13(4), 246–255. doi:10.1159/000279626.
25. Hill, M., Finning, K., Martin, P., Hogg, J., Meaney, C., Norbury, G., et al. (2011a). Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clinical Genetics, 80(1), 68–75. doi:10.1111/j.1399-0004.2010.01533.x.
26. Hill, M., Compton, C., Lewis, C., Skirton, H., & Chitty, L. (2011b). Determination of foetal sex in pregnancies at risk of haemophilia: a qualitative study exploring the clinical practices and attitudes of health professionals in the United Kingdom. Haemophilia, 18(4), 575–583. doi:10.1111/j.1365-2516.2011.02653.x.
27. Hill, M., Taffinder, S., Chitty, L. S., & Morris, S. (2011c). Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England. Prenatal Diagnosis, 31(3), 267–273. doi:10.1002/pd.2680.
28. Hill, M., Fisher, J., Chitty, L. S., & Morris, S. (2012). Women’s and health professionals’ preferences for prenatal tests for Down syndrome: a discrete choice experiment to contrast noninvasive prenatal diagnosis with current invasive tests. Genetics in Medicine, 14(11), 905–913. doi:10.1038/gim.2012.68.
29. Hill, M., Karunaratna, M., Lewis, C., Forya, F., & Chitty, L. (2013). Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom. American Journal of Medical Genetics, 161A(7), 1612–1618. doi:10.1002/ajmg.a.35972.
30. Kellogg, G., Slattery, L., Hudgins, L., & Ormond, K. (2014). Attitudes of mothers of children with Down syndrome towards noninvasive prenatal testing. Journal of Genetic Counseling. doi:10.1007/s10897-014-9694-7. Epub ahead of print.
31. Kelly, S. E., & Farrimond, H. R. (2012). Non-invasive prenatal genetic testing: a study of public attitudes. Public Health Genomics, 15(2), 73–81. doi:10.1159/000331254.
32. Kitzman, J. O., Snyder, M. W., Ventura, M., Lewis, A. P., Qiu, R., & Simmons, L. E. (2012). Noninvasive whole-genome sequencing of a human fetus. Science Translational Medicine, 4(137), 137–176. doi:10.1126/scitranslmed.3004323.
33. Kopesky, J. W., Veach, P. M., Lian, F., & Leroy, B. S. (2011). Where are the males? Gender differences in undergraduates’ interest in and perceptions of the genetic counseling profession. Journal of Genetic Counseling, 20(4), 341–354. doi:10.1007/s10897-011-9365-x.
34. Lench, N., Barrett, A., Fielding, S., McKay, F., Hill, M., Jenkins, L., et al. (2013). The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made. Prenatal Diagnosis, 33(6), 555–562. doi:10.1002/pd.4124.
35. Lewis, C., Hill, M., Skirton, H., & Chitty, L. S. (2012). Non-invasive prenatal diagnosis for fetal sex determination: benefits and disadvantages from the service users’ perspective. European Journal of Human Genetics, 20(11), 1127–33. doi:10.1038/ejhg.2012.50.
36. Lo, Y. M. D., Corbetta, N., Chamberlain, P. F., Rai, V., Sargent, I. L., Redman, C. W., & Wainscoat, J. S. (1997). Presence of fetal DNA in maternal plasma and serum. Lancet, 350, 485–487.
37. Lo, Y. M., Chan, K. C., Sun, H., Chen, E. Z., Jiang, P., Lun, F. M., et al. (2010). Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Science Translational Medicine, 2, 61–91. doi:10.1126/scitranslmed.3001720.
38. Maliszewski, K. (2010). An Assessment of Genetic Counselors’ Opinions on How Non-Invasive Prenatal Diagnosis May Impact Genetic Counseling Services. Brandeis Institutional Repository, Masters Thesis. Retrieved November 14, 2011 from http://bir.brandeis.edu/bitstream/handle/10192/24065/Maliszewski_GeneticCounselorsOpinionsOnNIPD.pdf?sequence=1
39. Middleton, A., Patch, C., Wiggins, J., Barnes, K., Crawford, G., Benjamin, C., & Bruce, A. (2014). Position Statement on opportunistic genomic screening from the Association of Genetic Nurses and Counselors (UK and Ireland). European Journal of Human Genetics. doi:10.1038/ejhg.2013.301.
40. Morris, S., Karlsen, S., Chung, N., Hill, M., & Chitty, L. S. (2014). Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down's syndrome using cell free fetal DNA in the UK National Health Service. Public Library of Science One, 9(4), e93559. doi:10.1371/journal.pone.0093559.
41. Newson, A. J. (2008). Ethical aspects from non-invasive fetal diagnosis. Seminars in Fetal and Neonatal Medicine, 13(2), 103–108. doi:10.1016/j.siny.2007.12.004.
42. NICE: National Institute for Clinical Evidence (2008). Clinical Guideline:Antenatal Care- routine care for the healthy pregnant woman. Retrieved June 9, 2014 from http://www.nice.org.uk/nicemedia/live/11947/40145/40145.pdf.
43. Novick, G. (2008). Is There a Bias Against Telephone Interviews In Qualitative Research? Research Nurse Health, 31(4), 391–398.
44. Ormondo, K. E. (2013). Genetic counseling to “genomic counseling”. Molecular Genetics and Genomic Medicine, 1(4), 189–193. doi:10.1002/mgg3.45.
45. Potter, B. K., O'Reilly, N., Etchegary, H., Howley, H., Graham, I. D., Walker, M., et al. (2008). Exploring informed choice in the context of prenatal testing: findings from a qualitative study. Health Expectations, 11(4), 355–365. doi:10.1111/j.1369-7625.2008.00493.x.
46. Rothman, B. K. (1993). The tentative pregnancy: then and now. Fetal Diagnosis Theroy, 8, 60–63. suppl.1.
47. Sayres, L. C., Allyse, M., Norton, M. E., & Cho, M. K. (2011). Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenatal Diagnosis, 31, 1070–1076. doi:10.1002/pd.2835.
48. Schmitz, D., Henn, W., & Netzer, C. (2009). Commentary: No risk, no objections? Ethical pitfalls of cell-free fetal DNA and RNA testing. British Medical Journal, 339, b2690. doi:10.1136/bmj.b2690.
49. Silcock, C., Chitty, L. and Liao, L.M. (2012). Will the introduction of non-invasive diagnosis for Down’s Syndrome influence informed choice? (Poster presented at the British Human Genetics Conference, Warwick University, UK 17-19 September 2012)
50. Skirton, H., & Patch, C. (2013). Factors affecting the clinical use of non-invasive prenatal testing: a mixed methods systematic review. Prenatal Diagnosis, 33(6), 532–541.
51. Skirton, H., Kerzin-Storrar, L., Barnes, C., Hall, G., Longmuir, M., Patch, C., et al. (2013a). Building the genetic counsellor profession in the United kingdom: two decades of growth and development. Journel of Genetic Counseling, 22(6), 902–906. doi:10.1007/s10897-012-9560-4.
52. Skirton, H., Cordier, C., Lambert, D., Hosterey Ugander, U., Voelckel, M. A., & O’Connar, A. (2013b). A study of the practice of individual genetic counsellors and genetic nurses in Europe. Journal of Community Genetics, 4(1), 69–75. doi:10.1007/s12687-012-0119-8.
53. Smith, E. M. (2005). Telephone interviewing in healthcare research: A summary of the evidence. Nurse Researcher; 12(3), 32–41.
54. Strauss, A., & Corbin, J. (1998). Basics of Qualitative Research Techniques and Procedures for Developing Grounded Theory (2nd ed.). London, England: Sage Publications.
55. Taylor, J. B., Chock, V. Y., & Hudgins, L. (2014). NIPT in a Clinical Setting: An analysis of Uptake in the First Months of Clinical Availability. Journal of Genetic Cousnelling, 23(1), 72–78. doi:10.1007/s10897-013-9609-z.
56. Tischler, R., Hudgins, L., Blumenfeld, Y. J., Greely, H. T., & Ormond, K. E. (2011). Noninvasive prenatal diagnosis: pregnant women’s interest and expected uptake. Prenatal Diagnosis, 31, 1292–1299. doi:10.1002/pd.2888.
57. Tsouroufil, M. (2011). Routinisation and constraints on informed choice in a one-stop clinic offering first trimester chromosomal antenatal screening for Down syndrome. Midwifery, 27(4), 431–4366. doi:10.1016/j.midw.2010.02.011.
58. United Kingdom Genetic Testing Network (2013). Gene dossiers. Retrieved May 26, 2014, from http://ukgtn.nhs.uk/find-a-test/search-by-disorder-gene/test-service/fgfr3-related-skeletal-dysplasias-panel-test-nipd-654/.
59. van den Berg, M., Timmermans, D. R., Ten, K. L. P., van Vugt, J. M., & van der Wal, G. (2005). Are pregnant women making informed choices about prenatal screening? Genetics in Medicine, 7(5), 332–8.
60. van den Heuvel, A., Chitty, L., Dormandy, E., Newson, A., Deans, Z., Attwood, S., et al. (2010). Will the Introduction of Non-Invasive Prenatal Diagnostic Testing Erode Informed Choices? An Experimental Study of Health Care Professionals. Patient Education and Counseling, 78(1), 24–28. doi:10.1016/j.pec.2009.05.014Will.
61. Williams, C., Alderson, P., & Farsides, B. (2002). What constitutes ‘balanced’ information in the practitioner’s portrayal of Down syndrome? Midwifery, 18, 230–7.
62. Wright, M. F., Lewis, K. L., Fisher, T. C., Hooker, G. W., Emanuel, T. E., Biesecker, L. G., & Biesecker, B. B. (2014). Preferences for results delivery from exome sequencing/genome. Genetics in Medicine. doi:10.1038/gim.2013.170.
63. Yotsumoto, J., Sekizawa, A., Koide, K., Purwosunu, Y., Ichizuka, K., Matsuoka, R., et al. (2012). Attitudes toward non-invasive prenatal diagnosis among pregnant women and health professionals in Japan. Prenatal Diagnosis, 32(7), 674–679. doi:10.1002/pd.3886.